Cancer Biomarker Market Forecast: Emerging Technologies, Competition & Strategies of Key Players, Regional Analysis and Forecast By 2023


Cancer Biomarker Market Forecast Research Report: By Types (Protein Biomarker, Genetic Biomarker), By Applications (Diagnostic, Prognostic, Therapeutic), By End Users (Pharmaceutical and Biotechnology Companies, Diagnostic Companies) – Forecast till 2023

Cancer biomarkers biochemical entities that are released during the presence of a tumor, indicating the presence of cancer in the body. Targeting biomarkers in cancer treatment are becoming a standard in the era of precision medicine. Market Research Future (MRFR) has thoroughly studied the trends and patterns in the global Cancer Biomarker Market Forecast over the forecast period of 2017-2023 in a detailed study. MRFR asserted that the cancer biomarker is likely to strike a CAGR of 15.8% over the forecast period.

The increasing burden of oncological disorders has resulted in the move towards early detection and preventive approach towards cancer. Extensive research is being carried out to further understand the role of biomarkers and come up with new biomarkers to predict treatment effectiveness and treatment activity in various oncology disorders. This coupled with massive investment by both public, and private entities have augmented the growth of the Cancer Biomarker Market Forecast. The growing popularity of personalized medicine is a key factor in enhancing the growth of the Cancer Biomarker Market Forecast. Personalized medicine hinges on biomarkers in extracting information that is relevant for diagnosis, prognosis, and therapy and is core to the personalized medicine field. Biomarker-driven approach can accelerate the drug development process in cancer, and various pharmaceutical companies are outlaying massive investments in R&D activities which are expected to augment the growth of the market over the forecast period. Furthermore, cancer biomarkers are an area of active research of the US FDA. Recent years have witnessed the approval of various cancer biomarkers and has paved the way for the expansion of the Cancer Biomarker Market Forecast.

On the contrary, low benefit-cost ratio associated with the development of cancer biomarkers is likely to restrain the growth of the global Cancer Biomarker Market Forecast.

 

Segmentation
The global Cancer Biomarker Market Forecast has been segmented based on type, application, and end user.

By type, the Cancer Biomarker Market Forecast has been segmented into protein biomarker, genetic biomarker, and others.

By application, the Cancer Biomarker Market Forecast has been segmented into diagnostic, prognostic and therapeutic. The diagnostic segment has been further segmented into imaging and non- Imaging.

By end user, the Cancer Biomarker Market Forecast has been segmented into pharmaceutical and biotechnology companies, diagnostic tool companies, healthcare it/big data companies, clinical laboratories          

Browse Complete Report : https://www.marketresearchfuture.com/reports/cancer-biomarker-market-5378

Regional Analysis
By region, the Cancer Biomarker Market Forecast has been segmented into the Americas, Asia Pacific (APAC), Europe, and the Middle East & Africa (MEA).

The Americas account for the largest share of the Cancer Biomarker Market Forecast. The high incidence rate of cancer and rapid advances in the cancer biomarker arena to come up with new drugs and effective therapies is supporting the growth of the market.

The Europe market is driven by rigorous clinical trials and government funding for the same.

The influx of investment for R&D by both public and private sector is driving the growth of the APAC Cancer Biomarker Market Forecast. In addition, increasing prevalence of cancer has evoked extensive R&D activities for the development of new therapies and drugs.

MRFR projects relatively slow growth in the MEA Cancer Biomarker Market Forecast. Low penetration of advanced diagnostics and treatment facilities and lack of awareness hinders the growth of the market.

Competitive Landscape
F. Hoffmann-La Roche AG (Switzerland), PerkinElmer, Inc. (U.S.), Bristol-Myers Squibb (U.S.), Novartis AG (Switzerland), Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories (U.S.), Merck & Co., Inc. (U.S.), Becton Dickinson (U.S.), Abbott Laboratories (U.S.), Pfizer Inc. (U.S.), QIAGEN N.V (U.S.), GlaxoSmithKline Plc. (U.S.), Illumina Inc. (U.S.), and Eli Lilly and Company (U.S.) are the distinguished players in the Cancer Biomarker Market Forecast.

Industry Updates
April 2019 - Scientists at the University of Southern California, US, are researching the presence of polymorphisms, specific genes known for detecting the presence of cancerous cells. The success of these findings can culminate in the use of these markers for detecting colorectal cancer at a preventive stage.

Comments

Post a Comment

Popular posts from this blog

Transcatheter Market Size, Analytical Overview, Growth Factors, Demand and Trends Forecast to 2023

Transcatheter Market Research Report: By Type of Treatment (Transfemoral Approach, Transapical Approach, and Others), by Product Type (TAVR and TMVR), by End-User (Hospitals, Ambulatory Surgical Centers, Others), and by Region–Forecast Till 2023 Transcatheter Market Overview: Transcatheter Market is a negligibly invasive procedure which is used to change the valve in patients with cardiac stenosis without eliminating the old or damaged valve. It is one of the treatment procedures frequently used to replace the damaged heart valve. Transcatheters have drastically altered the outlook of treatment with minimally invasive procedures in nearly all therapeutic areas. The focus towards cardiovascular diseases has grown recently owing to rising number of deaths caused by the condition. Due to this factor, a large number of firms in the market are introducing better devices and accessories for the treatment of cardiovascular diseases. Thus, the mounting prevalence of cardiovascular ...
Read more

Healthcare Chatbots Market : Key Growth Factor, Industry Analysis 2019 – 2023

  Overview: The global  Healthcare Chatbots Market  is estimated to garner nearly USD 316.85 million by 2023, states Market Research Future (MRFR) in its latest report. It can experience 21.10% CAGR over the forecast period (2018-2023) owing to the adoption of automated processes to alleviate workflow in the healthcare sector. Rising number of healthcare mobile applications users is expected to drive the market demand exponentially till 2023. According to the survey by HIMSS Mobile Technology Survey in 2015, nearly 180 healthcare providers engage patients via mobile apps. This has also been approved by doctors and hospitals. In addition, rising prevalence of chronic diseases is expected to induce the need for chatbots which can fetch health-related data of patients and assist with rapid diagnosis. Cancer patients and their caregivers increasingly rely on virtual assistants for medications and additional assistance. Increased in funding in research and development for evol...
Read more

Medical Drones Market : Key Players, Growth, Analysis by 2019 – 2027

  Medical Drones Market-Overview The need for medical drone facilities has increased considerably due to the situation caused by the COVID induce lockdowns globally. The  Medical Drones Market’s  report is efficiently analyzed as per MRFR, which provides outlooks for the global markets. The market is estimated to display an earning of USD 398 Million by 2025 with the backing of a CAGR of 24.4%. The surge in creating proper healthcare services for remote areas is estimated to further develop the medical drones market in the forecast period. Moreover, growing approval for innovative technology is estimated to promote the medical drone market’s augmentation in the impending period. Segmental Analysis The segmental analysis of the medical drones market is carried out on the basis of application, end-user, and region. The medical drone market’s application segment consists of blood transfer, vaccine transfer, and pharmaceutical/drug transfer. The end-user segment of the medica...
Read more